Symptoms of overdose include cold and clammy skin, confusion, nervousness, or severe restlessness, convulsions (seizures), severe dizziness, severe drowsiness, low blood pressure, pinpoint pupils of eyes, slow heartbeat, slow or troubled breathing and severe weakness.
Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an increased incidence of postoperative nausea.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Hydrocodone | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Magnesium sulfate | The therapeutic efficacy of Dezocine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Dezocine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Orphenadrine | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Pramipexole | Dezocine may increase the sedative activities of Pramipexole. |
| Ropinirole | Dezocine may increase the sedative activities of Ropinirole. |
| Rotigotine | Dezocine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Dezocine. |
| Sodium oxybate | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Thalidomide | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Dezocine is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Dezocine is combined with Desmopressin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Dezocine. |
| Codeine | The risk or severity of adverse effects can be increased when Codeine is combined with Dezocine. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dezocine. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Dezocine. |
| Oxycodone | The therapeutic efficacy of Oxycodone can be decreased when used in combination with Dezocine. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Dezocine. |
| Naltrexone | The therapeutic efficacy of Dezocine can be decreased when used in combination with Naltrexone. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Dezocine. |
| Alfentanil | The risk or severity of adverse effects can be increased when Alfentanil is combined with Dezocine. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Dezocine. |
| Levorphanol | The risk or severity of adverse effects can be increased when Levorphanol is combined with Dezocine. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Dezocine. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Dezocine. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Dezocine. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Dezocine is combined with Methadyl acetate. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Dihydroetorphine. |
| Diamorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Diamorphine. |
| Bezitramide | The risk or severity of adverse effects can be increased when Dezocine is combined with Bezitramide. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Ethylmorphine. |
| Etorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Etorphine. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Dezocine is combined with Dextromoramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Desomorphine. |
| Carfentanil | The risk or severity of adverse effects can be increased when Dezocine is combined with Carfentanil. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Dezocine is combined with Dihydrocodeine. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Dezocine is combined with Alphacetylmethadol. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Dihydromorphine. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Dezocine is combined with Ketobemidone. |
| DPDPE | The risk or severity of adverse effects can be increased when Dezocine is combined with DPDPE. |
| Lofentanil | The risk or severity of adverse effects can be increased when Dezocine is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Dezocine is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Dezocine is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Dezocine is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Dezocine is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Dezocine is combined with Nicomorphine. |
| Meptazinol | The therapeutic efficacy of Dezocine can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Dezocine is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Dezocine is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Dezocine is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Dezocine is combined with Carfentanil, C-11. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Dezocine is combined with Benzhydrocodone. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Dezocine. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Dezocine. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Dezocine. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dezocine. |
| Methylnaltrexone | Dezocine may increase the opioid antagonism activities of Methylnaltrexone. |
| Naloxegol | Dezocine may increase the opioid antagonism activities of Naloxegol. |
| Mirtazapine | Dezocine may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Duloxetine. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Paroxetine. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Sertraline. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Sibutramine. |
| Nefazodone | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Nefazodone. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Dezocine. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Alaproclate. |
| Ethanol | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Dezocine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dezocine. |
| Phentermine | Phentermine may increase the analgesic activities of Dezocine. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Dezocine. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Dezocine. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Dezocine. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Dezocine. |
| MMDA | MMDA may increase the analgesic activities of Dezocine. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Dezocine. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Dezocine. |